SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-216338
Filing Date
2004-12-20
Accepted
2004-12-20 14:13:35
Documents
4
Period of Report
2004-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR CORTEX PHARMACEUTICALS, INC. d8k.htm 8-K 19552
2 SECURITIES PURCHASE AGREEMENT DATED DECEMBER 14, 2004 dex1087.htm EX-10.87 293200
3 PRESS RELEASE DATED DECEMBER 15, 2004 dex991.htm EX-99.1 8012
4 GRAPHIC g34966img_34966.jpg GRAPHIC 12545
  Complete submission text file 0001193125-04-216338.txt   335408
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 041213645
SIC: 2834 Pharmaceutical Preparations